“GM-CSF has emerged as a potential biological target in treating severe COVID-19 (Zhou et al., 2020); this may mitigate neuropsychiatric sequelae by limiting MdC neuroinvasion.“ https://scholar.google.com.hk/scholar?as_ylo=2020&q=anosmia+gm-csf&hl=en&as_sdt=0,33#d=gs_qabs&u=%23p%3DGoaq9TmKdCgJ… $HGEN will treat #longhaulers NeuroCOVID - #COVID19 - not Roche, Incy or CYDY - HGEN.